Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2004 1
2005 1
2006 4
2007 4
2008 1
2009 1
2011 1
2012 3
2013 1
2014 2
2015 3
2017 7
2018 4
2019 4
2020 8
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients.
Johnsen S, Sattler SM, Miskowiak KW, Kunalan K, Victor A, Pedersen L, Andreassen HF, Jørgensen BJ, Heebøll H, Andersen MB, Marner L, Hædersdal C, Hansen H, Ditlev SB, Porsbjerg C, Lapperre TS. Johnsen S, et al. Among authors: lapperre ts. ERJ Open Res. 2021 Aug 2;7(3):00205-2021. doi: 10.1183/23120541.00205-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34345629 Free PMC article.
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial.
Sivapalan P, Ulrik CS, Lapperre TS, Bojesen RD, Eklöf J, Browatzki A, Wilcke JT, Gottlieb V, Håkansson KEJ, Tidemandsen C, Tupper O, Meteran H, Bergsøe C, Brøndum E, Bødtger U, Bech Rasmussen D, Graff Jensen S, Pedersen L, Jordan A, Priemé H, Søborg C, Steffensen IE, Høgsberg D, Klausen TW, Frydland MS, Lange P, Sverrild A, Ghanizada M, Knop FK, Biering-Sørensen T, Lundgren JD, Jensen JS; ProPAC-COVID writing group on behalf of the ProPAC-COVID Study Group. Sivapalan P, et al. Among authors: lapperre ts. Eur Respir J. 2022 Jan 6;59(1):2100752. doi: 10.1183/13993003.00752-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34083403 Free PMC article. Clinical Trial.
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study.
Kamstrup P, Sivapalan P, Eklöf J, Hoyer N, Ulrik CS, Pedersen L, Lapperre TS, Harboe ZB, Bodtger U, Bojesen RD, Håkansson KEJ, Tidemandsen C, Armbruster K, Browatzki A, Meteran H, Meyer CN, Skaarup KG, Lassen MCH, Lundgren JD, Biering-Sørensen T, Jensen JU. Kamstrup P, et al. Among authors: lapperre ts. Int J Infect Dis. 2021 Jul;108:370-376. doi: 10.1016/j.ijid.2021.05.076. Epub 2021 Jun 1. Int J Infect Dis. 2021. PMID: 34087484 Free PMC article.
Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International Study.
Miravitlles M, Sliwinski P, Rhee CK, Costello RW, Carter V, Tan JHY, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price DB; Respiratory Effectiveness Group (REG); following investigators participated in the study. Miravitlles M, et al. Among authors: lapperre ts. Arch Bronconeumol (Engl Ed). 2021 Feb;57(2):122-129. doi: 10.1016/j.arbres.2020.06.003. Epub 2020 Jul 21. Arch Bronconeumol (Engl Ed). 2021. PMID: 32709534 English, Spanish.
"High-Risk" Clinical and Inflammatory Clusters in COPD of Chinese Descent.
Tiew PY, Ko FWS, Narayana JK, Poh ME, Xu H, Neo HY, Loh LC, Ong CK, Mac Aogáin M, Tan JHY, Kamaruddin NH, Sim GJH, Lapperre TS, Koh MS, Hui DSC, Abisheganaden JA, Tee A, Tsaneva-Atanasova K, Chotirmall SH. Tiew PY, et al. Among authors: lapperre ts. Chest. 2020 Jul;158(1):145-156. doi: 10.1016/j.chest.2020.01.043. Epub 2020 Feb 22. Chest. 2020. PMID: 32092320 Free PMC article.
50 results